Status:
RECRUITING
Digital Solution for Salutogenic Brain Health (DiSaB): A Pilot Protocol for Clinical Implementation
Lead Sponsor:
National University of Singapore
Conditions:
Chronic Condition
Eligibility:
All Genders
40-64 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to develop and learn if a digitally delivered brain health intervention (DiSaB) can help improve cognitive, physical and psychosocial health in middle-aged adults wi...
Detailed Description
The effectiveness of the DiSaB intervention implementation at primary care setting amongst participants with long term conditions will be evaluated using the Reach, Effectiveness, Adoption, Implementa...
Eligibility Criteria
Inclusion
- Aged 40 - 55 years old
- Have hypertension, hyperlipidaemia and/or type-2 diabetes
- Ability to provide written informed consent
- Posses sufficient English language skills in reading, writing and speaking
- Multimorbidity conditions are also acceptable with the exception of life-threatening co-morbidities with life expectancy of less than one year
- Total Risk Score (TRS) for cognitive impairment of at least 3
Exclusion
- Physical, visual and/or hearing impairment
- Language impairment (i.e. severe dysarthria or aphasia)
- Not within age range listed
- Major or active psychiatric conditions
- Diagnosis of dementia
- Do not own a mobile device capable of downloading applications (i.e. Zoom), and/or do not have access to internet connection
Key Trial Info
Start Date :
April 2 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT06582316
Start Date
April 2 2025
End Date
June 1 2026
Last Update
May 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National University Polyclinics
Singapore, Singapore